Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer

1. Felip, E.
2. Metro, G.
3. Tan, D.S.W.
4. Wolf, J.
5. Mark, M.
6. Boyer, M.
7. Hughes, B.G.M.
8. Bearz, A.
9. Moro-Sibilot, D.
10. Le, X.
11. Puente, J.
12. Massuti, B.
13. Tiedt, R.
14. Wang, Y.
15. Xu, C.
16. Mardjuadi, F.I.
17. Cobo, M.